Treatment outcome of patients with intermediate- and poor-prognosis metastatic testicular cancer in the 2000s: A multicenter experience in Japan

被引：0

作者：

Kojima, Takahiro

Kawai, Koji

Tsuchiya, Kunihiko

Abe, Takashige

Shinohara, Nobuo

Tanaka, Toshiaki

Masumori, Naoya

Yamada, Shigeyuki

Arai, Yoichi

Narita, Shintaro

Tsuchiya, Norihiko

Habuchi, Tomonori

Nishiyama, Hiroyuki

机构：

[1] Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki, Japan

[2] Univ Tsukuba, Dept Urol, Fac Med, Tsukuba, Ibaraki, Japan

[3] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan

[4] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan

[5] Sapporo Med Univ, Sch Med, Dept Urol Surg & Androl, Sapporo, Hokkaido, Japan

[6] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan

[7] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan

[8] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期

关键词：

D O I：

10.1200/jco.2015.33.7_suppl.397

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

397

引用

页数：1

共 50 条

[1] IMPROVED OUTCOME FOR POOR-PROGNOSIS METASTATIC GERM CELL CANCER: A SINGLE CENTER EXPERIENCE IN JAPAN
Yamada, Shigeyuki
Saito, Hideo
Kaiho, Yasuhiro
Ito, Akihiro
Ishidoya, Shigeto
Arai, Yoichi
JOURNAL OF UROLOGY, 2010, 183 (04): : E328 - E329
[2] IDENTIFICATION OF PRETREATMENT PROGNOSTIC FACTOR FOR PATIENTS WITH INTERMEDIATE- AND POOR-RISK METASTATIC TESTICULAR CANCER
Kawai, Koji
Oikawa, Takehiro
Onozawa, Mizuki
Johraku, Akira
Sekido, Noritoshi
Miyanaga, Naoto
Shimazui, Toru
Akaza, Hideyuki
JOURNAL OF UROLOGY, 2009, 181 (04): : 198 - 198
[3] Phase II trial of dose-dense BEP for intermediate- and poor-prognosis metastatic germ cell tumors.
Rimmer, Y. L.
Chester, J. D.
Stark, D. P.
Joffe, J. K.
Shamash, J.
White, J. D.
Upton, N.
Wason, J.
Parashar, D.
Williams, M. V.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[4] More experienced centers achieve higher survival rates in poor-prognosis testicular cancer patients
不详
ONCOLOGY-NEW YORK, 1999, 13 (10): : 1358 - 1358
[5] A retrospective multicenter study of MSKCC poor-prognosis patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib
Heng, D. Y.
Elson, P.
Golshayan, A. R.
Warren, M. A.
Kollmannsberger, C.
Chi, K. N.
Cheng, T.
North, S. A.
Garcia, J. A.
Bukowski, R. M.
Rini, B. I.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[6] Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
Norbert Gleicher
Vitaly A. Kushnir
Aritro Sen
Sarah K. Darmon
Andrea Weghofer
Yan-Guang Wu
Qi Wang
Lin Zhang
David F. Albertini
David H. Barad
Journal of Translational Medicine, 14
[7] Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
Gleicher, Norbert
Kushnir, Vitaly A.
Sen, Aritro
Darmon, Sarah K.
Weghofer, Andrea
Wu, Yan-Guang
Wang, Qi
Zhang, Lin
Albertini, David F.
Barad, David H.
JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
[8] CT Staging to Triage Selection of Patients With Poor-Prognosis Rectal Cancer for Neoadjuvant Treatment
Ortega, Cinthia D.
Rocha, Manoel S.
AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 358 - 364
[9] CMIF-P TREATMENT IN PATIENTS WITH POOR-PROGNOSIS ADVANCED BREAST-CANCER
KUHRER, I
LUDWIG, H
SCHEITHAUER, W
ZIELINSKI, C
BLUT, 1987, 55 (04): : 362 - 362
[10] PROGNOSTIC FACTORS IN UNSELECTED PATIENTS WITH NONSEMINOMATOUS METASTATIC TESTICULAR CANCER - A MULTICENTER EXPERIENCE
AASS, N
KLEPP, O
CAVALLINSTAHL, E
DAHL, O
WICKLUND, H
UNSGAARD, B
BALDETORP, L
AHLSTROM, S
FOSSA, SD
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) : 818 - 826

← 1 2 3 4 5 →